Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome

Neurology. 1991 Aug;41(8):1302-5. doi: 10.1212/wnl.41.8.1302.

Abstract

In patients with Guillain-Barré syndrome (GBS) soluble interleukin-2 receptor (sIL-2R) levels were elevated compared with those of patients with other neurologic diseases (OND), and of healthy controls. Smaller increases in sIL-2R levels occurred in OND patients compared to healthy subjects. Monitoring of GBS patients clearly demonstrated that decreases in sIL-2R levels correlated with clinical recovery. Thus, T-cell activation may be relevant in the pathogenesis of GBS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Central Nervous System Diseases / blood
  • Central Nervous System Diseases / physiopathology
  • Family Health
  • Humans
  • Nervous System Diseases / blood
  • Nervous System Diseases / physiopathology
  • Osmolar Concentration
  • Polyradiculoneuropathy / blood*
  • Polyradiculoneuropathy / genetics
  • Polyradiculoneuropathy / physiopathology
  • Receptors, Interleukin-2 / blood*
  • Reference Values
  • Solubility

Substances

  • Receptors, Interleukin-2